克拉约瓦传染病门诊治疗中、重度COVID-19的中间分析

Q4 Immunology and Microbiology Revista Romana de Boli Infectioase Pub Date : 2020-12-31 DOI:10.37897/RJID.2020.4.3
L. Giubelan, C. Pharmacy, L. Dragonu, A. Stoian, F. Dumitrescu
{"title":"克拉约瓦传染病门诊治疗中、重度COVID-19的中间分析","authors":"L. Giubelan, C. Pharmacy, L. Dragonu, A. Stoian, F. Dumitrescu","doi":"10.37897/RJID.2020.4.3","DOIUrl":null,"url":null,"abstract":"Objective. Description and differentiation of moderate and severe forms of COVID-19 diagnosed and treated in Infectious Diseases Clinic, „Victor Babeş“ Infectious Diseases and Pneumology Hospital from Craiova. Material and method. Retrospective study (March 2020 – July 2020) of the first 300 hospitalized cases comparing the moderate and severe forms of COVID-19 from a clinical and biological point of view. Results. 56 moderate and 33 severe cases were recorded;between them there are a series of differences with statistical significance: age of patients (49.5 ± 16.13, p < 0.0001), number of obese patients (12 vs. 14, p = 0.06), with cardiovascular suffering, (8 vs. 18, p < 0.0001), diabetes (9 vs. 15, p = 0.005) or neoplasms (2 vs. 7, p = 0.02). Several severely ill patients have dyspnoea (14 vs. 24, p < 0.0001), pulmonary rales (8 vs. 13, p = 0.01), elevated systolic blood pressure (2 vs. 9, p = 0.01), coma (0 vs. 5, p = 0.01) or radio-logical image of bronchopneumonia (0 vs. 6, p = 0.004). Critically ill patients have a higher leukocyte count (6,176.07±2,512.05 vs. 8,666.67±4,565.88, p=0.01), higher ESR at 1 hour (43.05±18.09 vs. 71.18±30.8 mm, p < 0.0001), higher level of C-reactive protein (29.62±19.81 vs. 43.46±18.01 mg/l, p = 0.01), serum lactate (1.19±0.91 vs. 3.47±3.84 mEq/l, p = 0.006), blood glucose (112.5±25.01 vs. 304.45±273.58 mg/ dl, p < 0.0001), D dimers (518.7±455.32 vs. 1,314.22±1,347.54 µg/ml, p < 0.0001), troponin (1.8±4.02 vs. 90.81±202.08 mg/l, p < 0.0001);the neutrophil-to-lymphocyte ratio is higher in severe forms (3.66±1.2 vs. 6.21±4.21, p < 0.0001). Of the 33 patients with severe forms 16 (approximately 50% of them, respectively 5.33% of the 300 cases) died. Conclusions. Patients with severe forms of COVID-19 are much older and have more comorbidities (es-pecially obesity, cardiovascular disease, diabetes or malignancies). For the early detection of severe forms, physicians should detect dyspnea, low oxygen saturation or the presence of pulmonary rales, more com-monly encountered in severe forms. Tests for inflammation and procoagulant status are significantly better expressed in patients with severe forms. At the level of the studied group, the glycemic control was subop-timal for severe forms of the disease. Despite the intensive care support, about half of those admitted with severe forms (5.33% of all cases) died. © 2020, Amaltea Medical Publishing House. All rights reserved.","PeriodicalId":53394,"journal":{"name":"Revista Romana de Boli Infectioase","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An intermediate analysis of moderate and severe forms of COVID-19 treated in Craiova Infectious Disease Clinic\",\"authors\":\"L. Giubelan, C. Pharmacy, L. Dragonu, A. Stoian, F. Dumitrescu\",\"doi\":\"10.37897/RJID.2020.4.3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective. Description and differentiation of moderate and severe forms of COVID-19 diagnosed and treated in Infectious Diseases Clinic, „Victor Babeş“ Infectious Diseases and Pneumology Hospital from Craiova. Material and method. Retrospective study (March 2020 – July 2020) of the first 300 hospitalized cases comparing the moderate and severe forms of COVID-19 from a clinical and biological point of view. Results. 56 moderate and 33 severe cases were recorded;between them there are a series of differences with statistical significance: age of patients (49.5 ± 16.13, p < 0.0001), number of obese patients (12 vs. 14, p = 0.06), with cardiovascular suffering, (8 vs. 18, p < 0.0001), diabetes (9 vs. 15, p = 0.005) or neoplasms (2 vs. 7, p = 0.02). Several severely ill patients have dyspnoea (14 vs. 24, p < 0.0001), pulmonary rales (8 vs. 13, p = 0.01), elevated systolic blood pressure (2 vs. 9, p = 0.01), coma (0 vs. 5, p = 0.01) or radio-logical image of bronchopneumonia (0 vs. 6, p = 0.004). Critically ill patients have a higher leukocyte count (6,176.07±2,512.05 vs. 8,666.67±4,565.88, p=0.01), higher ESR at 1 hour (43.05±18.09 vs. 71.18±30.8 mm, p < 0.0001), higher level of C-reactive protein (29.62±19.81 vs. 43.46±18.01 mg/l, p = 0.01), serum lactate (1.19±0.91 vs. 3.47±3.84 mEq/l, p = 0.006), blood glucose (112.5±25.01 vs. 304.45±273.58 mg/ dl, p < 0.0001), D dimers (518.7±455.32 vs. 1,314.22±1,347.54 µg/ml, p < 0.0001), troponin (1.8±4.02 vs. 90.81±202.08 mg/l, p < 0.0001);the neutrophil-to-lymphocyte ratio is higher in severe forms (3.66±1.2 vs. 6.21±4.21, p < 0.0001). Of the 33 patients with severe forms 16 (approximately 50% of them, respectively 5.33% of the 300 cases) died. Conclusions. Patients with severe forms of COVID-19 are much older and have more comorbidities (es-pecially obesity, cardiovascular disease, diabetes or malignancies). For the early detection of severe forms, physicians should detect dyspnea, low oxygen saturation or the presence of pulmonary rales, more com-monly encountered in severe forms. Tests for inflammation and procoagulant status are significantly better expressed in patients with severe forms. At the level of the studied group, the glycemic control was subop-timal for severe forms of the disease. Despite the intensive care support, about half of those admitted with severe forms (5.33% of all cases) died. © 2020, Amaltea Medical Publishing House. All rights reserved.\",\"PeriodicalId\":53394,\"journal\":{\"name\":\"Revista Romana de Boli Infectioase\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Romana de Boli Infectioase\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37897/RJID.2020.4.3\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Immunology and Microbiology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Romana de Boli Infectioase","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37897/RJID.2020.4.3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Immunology and Microbiology","Score":null,"Total":0}
引用次数: 0

摘要

目标。克拉约瓦“维克多·巴贝茨”传染病与肺炎医院传染病门诊诊治的中、重度新冠肺炎描述与区分材料和方法。对首批300例住院病例(2020年3月至2020年7月)进行回顾性研究,从临床和生物学角度比较中度和重度COVID-19。结果:中度患者56例,重度患者33例,患者年龄(49.5±16.13,p < 0.0001)、肥胖患者数(12例vs. 14例,p = 0.06)、合并心血管疾病患者数(8例vs. 18例,p < 0.0001)、糖尿病患者数(9例vs. 15例,p = 0.005)、肿瘤患者数(2例vs. 7例,p = 0.02)等差异均有统计学意义。一些重症患者有呼吸困难(14比24,p < 0.0001)、肺音(8比13,p = 0.01)、收缩压升高(2比9,p = 0.01)、昏迷(0比5,p = 0.01)或支气管肺炎的影像学表现(0比6,p = 0.004)。危重患者有更高的白细胞计数(vs 8666 .67 2512 .05 6176 .07点±±4565 .88点,p = 0.01),更高的ESR 1小时(43.05±18.09和71.18±30.8毫米,p < 0.0001),高c反应蛋白水平(29.62±19.81和43.46±18.01 mg / l, p = 0.01),血清乳酸(1.19±0.91和3.47±3.84毫克当量/ l, p = 0.006),血糖(112.5±25.01和304.45±273.58 mg / dl, p < 0.0001), D二聚体(518.7±455.32 vs 1314 .22±1347点µg / ml, p < 0.0001),肌钙蛋白(1.8±4.02和90.81±202.08 mg / l,中性粒细胞与淋巴细胞的比值在严重形式中较高(3.66±1.2比6.21±4.21,P < 0.0001)。在33例重症患者中,16例死亡(约占50%,分别占300例的5.33%)。结论。严重形式的COVID-19患者年龄大得多,并有更多合并症(特别是肥胖、心血管疾病、糖尿病或恶性肿瘤)。对于早期发现的严重形式,医生应发现呼吸困难,低氧饱和度或肺部啰音的存在,更常见的严重形式。炎症和促凝状态测试在严重形式的患者中明显更好地表达。在研究组的水平上,对于严重形式的疾病,血糖控制是次优的。尽管有重症监护支持,但约有一半的重症患者(占所有病例的5.33%)死亡。©2020,Amaltea医学出版社。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
An intermediate analysis of moderate and severe forms of COVID-19 treated in Craiova Infectious Disease Clinic
Objective. Description and differentiation of moderate and severe forms of COVID-19 diagnosed and treated in Infectious Diseases Clinic, „Victor Babeş“ Infectious Diseases and Pneumology Hospital from Craiova. Material and method. Retrospective study (March 2020 – July 2020) of the first 300 hospitalized cases comparing the moderate and severe forms of COVID-19 from a clinical and biological point of view. Results. 56 moderate and 33 severe cases were recorded;between them there are a series of differences with statistical significance: age of patients (49.5 ± 16.13, p < 0.0001), number of obese patients (12 vs. 14, p = 0.06), with cardiovascular suffering, (8 vs. 18, p < 0.0001), diabetes (9 vs. 15, p = 0.005) or neoplasms (2 vs. 7, p = 0.02). Several severely ill patients have dyspnoea (14 vs. 24, p < 0.0001), pulmonary rales (8 vs. 13, p = 0.01), elevated systolic blood pressure (2 vs. 9, p = 0.01), coma (0 vs. 5, p = 0.01) or radio-logical image of bronchopneumonia (0 vs. 6, p = 0.004). Critically ill patients have a higher leukocyte count (6,176.07±2,512.05 vs. 8,666.67±4,565.88, p=0.01), higher ESR at 1 hour (43.05±18.09 vs. 71.18±30.8 mm, p < 0.0001), higher level of C-reactive protein (29.62±19.81 vs. 43.46±18.01 mg/l, p = 0.01), serum lactate (1.19±0.91 vs. 3.47±3.84 mEq/l, p = 0.006), blood glucose (112.5±25.01 vs. 304.45±273.58 mg/ dl, p < 0.0001), D dimers (518.7±455.32 vs. 1,314.22±1,347.54 µg/ml, p < 0.0001), troponin (1.8±4.02 vs. 90.81±202.08 mg/l, p < 0.0001);the neutrophil-to-lymphocyte ratio is higher in severe forms (3.66±1.2 vs. 6.21±4.21, p < 0.0001). Of the 33 patients with severe forms 16 (approximately 50% of them, respectively 5.33% of the 300 cases) died. Conclusions. Patients with severe forms of COVID-19 are much older and have more comorbidities (es-pecially obesity, cardiovascular disease, diabetes or malignancies). For the early detection of severe forms, physicians should detect dyspnea, low oxygen saturation or the presence of pulmonary rales, more com-monly encountered in severe forms. Tests for inflammation and procoagulant status are significantly better expressed in patients with severe forms. At the level of the studied group, the glycemic control was subop-timal for severe forms of the disease. Despite the intensive care support, about half of those admitted with severe forms (5.33% of all cases) died. © 2020, Amaltea Medical Publishing House. All rights reserved.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
11
审稿时长
4 weeks
期刊最新文献
COVID-19 pandemic complexities on endemic infectious disease management and diagnosis in poor countries Evaluation of carbohydrate and lipid metabolism dynamics in chronic HCV diabetic patients treated with direct antiviral agents Endocrine impact in infections including COVID-19 Neutrophil to lymphocyte ratio and immature granulocyte: assessing for promising parameters to monitor tuberculosis-diabetes mellitus patients Severe form of COVID-19 in a neonate with resuscitated cardio-respiratory arrest - Case presentation
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1